Jan 9 2010
HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.
FRAGMIN is an anticoagulant that prevents the formation of blood clots. GLIADEL Wafer is used to treat brain tumors.
"We are proud to expand our partnership with Eisai," says Marcia McLaughlin, president of Centron. "FRAGMIN and GLIADEL Wafer are important medicines. We look forward to becoming strategic and creative members of the brand teams."
Source:
HealthSTAR Communications